Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs VSAT✓SelectedUSD · VSATGSK vs VSAT performance historyLatest closeAs of-1.56%11/19
Stock and ETF performance explorer

GSK vs VSAT

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+52.9%
VSAT return
+216.1%
Excess return
-163.2%
Maximum drawdown
-28.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioVSATExcessAlpha
1D-1.6%-6.4%+4.8%-1.5%
7D-4.7%-13.7%+9.0%-4.5%
30D-4.7%+2.2%-6.9%-4.9%
3M-8.8%-19.8%+11.1%-8.6%
6M-4.6%-13.3%+8.7%-4.9%
YTD+1.0%+78.4%-77.4%-0.8%
1Y+6.9%+76.1%-69.2%+4.9%
All+52.9%+216.1%-163.2%+41.3%

Cumulative growth

Daily Returns

Daily percentage return beside VSAT.

Daily Out/Under-Performance

Portfolio return minus VSAT return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × VSAT return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded VSAT wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling